Monday, March 1, 2021

Repurposed arthritis drug did not significantly improve severe COVID-19 pneumonia

A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/2NQgYE1
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discover what triggers belly fat as we age

Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The discovery re...